Aura Biosciences Inc (AURA)
US Market

Aura Biosciences Inc (AURA) Cash flow


Aura Biosciences Inc Cash Flow

AURA's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, AURA's free cash flow was decreased by $-21.16M and operating cash flow was $-15.40M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -64.47M$ -54.60M$ -32.41M$ -24.32M$ -20.67M
Investing Cash Flow
$ -40.72M$ -67.87M$ -2.13M$ -771.00K$ -2.22M
Financing Cash Flow
$ 99.50M$ 95.63M$ 166.26M$ 10.04M$ 39.73M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 266.54M$ 122.37M$ 236.44M$ 17.49M$ 32.54M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
Issuance Of Capital Stock
$ 86.78M$ 86.65M$ 78.70M$ 9.91M$ 39.72M
Issuance Of Debt
Repayment Of Debt
---$ -34.00K$ -37.00K
Free Cash Flow
$ -49.73M$ -55.70M$ -34.53M$ -25.09M$ -22.89M
Domestic Sales
Foreign Sales
Currency in USD

Aura Biosciences Inc Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis